LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 238

Search options

  1. Book: Rheumatologie kompakt

    Pfeil, Alexander / Oelzner, Peter / Böttcher, Joachim / Lange, Uwe / Wolf, Gunter

    2024  

    Author's details Alexander Pfeil, Peter Oelzner, Joachim Böttcher, Uwe Lange, Guter Wolf (Hrsg.) ; mit Beiträgen von: C. Baerwald [und weitere]
    Keywords Rheumatologie ; Hausarzt ; Allgemeinmedizin ; Hardcover, Softcover / Medizin/Klinische Fächer
    Language German
    Size XII, 223 Seiten, Illustrationen, 27 cm x 21 cm
    Edition 1. Auflage
    Publisher Elsevier
    Publishing place München
    Publishing country Germany
    Document type Book
    Old title Vorangegangen ist
    HBZ-ID HT030365748
    ISBN 978-3-437-21209-3 ; 3-437-21209-5 ; 9783437098673 ; 3437098675
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book ; Thesis: Erhebung des Rehabilitationsbedarfes sowie Entwicklung von Therapieansätzen nach SARS-CoV-2-Infektion

    Lemhöfer, Christina / Stallmach, Andreas / Best, Norman / Lange, Uwe

    2023  

    Institution Friedrich-Schiller-Universität Jena
    Author's details von Dr. med. Christina Lemhöfer
    Language German ; English
    Size 106 Blätter, Illustrationen, Diagramme, 29,5 cm
    Publishing place Jena
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Habilitationsschrift, Friedrich-Schiller-Universität Jena, 2023
    Note Zeitschriftenaufsätze in englischer Sprache ; Kumulative Habilitationsschrift, enthält Zeitschriftenaufsätze ; Erteilung der Lehrbefähigung: 12.10.2023
    HBZ-ID HT030693361
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Book: Fachwissen Osteologie

    Abendrot, Klaus / Kurth, Andreas / Lange, Uwe

    2018  

    Author's details Andreas Kurth, Uwe Lange (Hrsg.) ; mit Beiträgen von Klaus Abendroth [und vielen weiteren]
    Keywords Altersmedizin ; Geriatrie ; Osteoporose ; Knochenkrankheit ; Osteologie
    Subject Osteopathie ; Knochenerkrankung
    Subject code 610
    Language German
    Size XXII, 313 Seiten, Illustrationen, Diagramme
    Edition 1. Auflage
    Publisher Elsevier
    Publishing place München
    Publishing country Germany
    Document type Book
    HBZ-ID HT019558058
    ISBN 978-3-437-22102-6 ; 3-437-22102-7 ; 9783437298943 ; 3437298941
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article ; Online: Update DVO-Leitlinie 2023 „Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern ab dem 50. Lebensjahr“ – Was ist neu für die Rheumatologie?

    Pfeil, Alexander / Lange, Uwe

    Zeitschrift fur Rheumatologie

    2024  

    Abstract: In October 2023, the organization of the German-speaking scientific osteological societies (DVO) published the revised guideline on the "Prophylaxis, diagnosis and treatment of osteoporosis in postmenopausal women and in men aged over 50." This review ... ...

    Title translation Update on the DVO Guideline 2023 "Prophylaxis, diagnosis and treatment of osteoporosis in postmenopausal women and in men aged over 50"-What's new for rheumatology?
    Abstract In October 2023, the organization of the German-speaking scientific osteological societies (DVO) published the revised guideline on the "Prophylaxis, diagnosis and treatment of osteoporosis in postmenopausal women and in men aged over 50." This review article reflects the new features of the guideline and their relevance in the care of patients with inflammatory rheumatic diseases.A key innovation is the change from the 10-year fracture risk to the 3‑year fracture risk. Basic diagnostics are currently performed without a defined fracture threshold. Treatment thresholds for specific osteological therapy constitute another key innovation, defined as 3% to < 5%, 5% to < 10%, and from 10% for vertebral body and femoral neck fractures. If the 3‑year fracture risk is > 10%, osteoanabolic therapy should primarily be carried out and antiresorptive therapy is initiated following osteoanabolic therapy. In addition, patients with osteoporosis and prolonged glucocorticoid therapy should primarily be treated osteoanabolically with teriparatide. In summary, the changes to the DVO guideline reflect the latest scientific study findings in osteology and lead to detailed differential therapy for osteoporosis.
    Language German
    Publishing date 2024-03-21
    Publishing country Germany
    Document type English Abstract ; Journal Article
    ZDB-ID 124985-x
    ISSN 1435-1250 ; 0340-1855 ; 0301-6382
    ISSN (online) 1435-1250
    ISSN 0340-1855 ; 0301-6382
    DOI 10.1007/s00393-024-01495-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Difficult to treat rheumatoid arthritis: Why profound differential diagnosis is important.

    Schulz, Nils / Lange, Uwe / Klemm, Philipp

    European journal of internal medicine

    2024  

    Language English
    Publishing date 2024-02-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2024.02.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Heat therapy in rheumatic and musculoskeletal diseases - an overview of clinical and molecular effects.

    Klemm, Philipp / Schulz, Nils / Boettger, Priyanka / Lange, Uwe

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

    2024  Volume 41, Issue 1, Page(s) 2322667

    Abstract: Rheumatic and musculoskeletal diseases (RMDs) usually lead to morphological and functional deficits of various extend, increased morbidity and a considerable loss of quality of life. Modern pharmacological treatment has become effective and can stop ... ...

    Abstract Rheumatic and musculoskeletal diseases (RMDs) usually lead to morphological and functional deficits of various extend, increased morbidity and a considerable loss of quality of life. Modern pharmacological treatment has become effective and can stop disease progression. Nonetheless, disease progression is often only slowed down. Moreover, pharmacological treatment does not improve functionality per se. Therefore, multimodal treatment of rheumatic disorders with physical therapy being a key element is of central importance for best outcomes. In recent years, research into physical medicine shifted from a sole investigation of its clinical effects to a combined investigation of clinical effects and potential changes in the molecular level (e.g., inflammatory cytokines and the cellular autoimmune system), thus offering new explanations of clinical effects of physical therapy. In this review we provide an overview of studies investigating different heat applications in RMDs, their effect on disease activity, pain and their influence on the molecular level.
    MeSH term(s) Humans ; Hot Temperature ; Quality of Life ; Musculoskeletal Diseases/therapy ; Disease Progression ; Muscular Diseases
    Language English
    Publishing date 2024-03-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 632526-9
    ISSN 1464-5157 ; 0265-6736
    ISSN (online) 1464-5157
    ISSN 0265-6736
    DOI 10.1080/02656736.2024.2322667
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Neues aus der physikalischen Medizin und Rehabilitation.

    Lange, Uwe / Meyer-Olson, Dirk

    Zeitschrift fur Rheumatologie

    2022  Volume 81, Issue 5, Page(s) 357–359

    Title translation New aspects of physical medicine and rehabilitation.
    MeSH term(s) Humans ; Physical and Rehabilitation Medicine
    Language German
    Publishing date 2022-05-31
    Publishing country Germany
    Document type Editorial
    ZDB-ID 124985-x
    ISSN 1435-1250 ; 0340-1855 ; 0301-6382
    ISSN (online) 1435-1250
    ISSN 0340-1855 ; 0301-6382
    DOI 10.1007/s00393-022-01215-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book ; Thesis: Untersuchungen zum Knochenstoffwechsel und zu pathogenetisch relevanten Faktoren der Osteopenie, Osteoporose bei ankylosierender Spondylitis

    Lange, Uwe

    2002  

    Author's details vorgelegt von Uwe Lange
    Keywords Bechterew-Krankheit ; Osteoporose ; Pathogenese
    Subject Knochenrarefikation ; Osteoporosis ; Ankylosierende Spondylitis ; Spondylarthritis ankylopoetica ; Spondylitis ankylopoetica ; Spondylitis ankylosans ; Morbus Bechterew ; Bechterew-Strümpell-Marie-Krankheit
    Language German
    Size 281 S. : Ill., graph. Darst.
    Publisher Köhler
    Publishing place Gießen
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Giessen, Univ., Habil.-Schr., 2001
    HBZ-ID HT013458533
    ISBN 3-935713-30-4 ; 978-3-935713-30-6
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  9. Article: Camurati-Engelmann Disease: A Case-Based Review About an Ultrarare Bone Dysplasia.

    Klemm, Philipp / Aykara, Iris / Lange, Uwe

    European journal of rheumatology

    2023  Volume 10, Issue 1, Page(s) 34–38

    Abstract: Camurati-Engelmann disease or progressive diaphyseal dysplasia is a rare hereditary disease that results in a symmetrical hyperostosis of the long bones (cortical thickening) and/or the base of the skull. Camurati-Engelmann disease is also associated ... ...

    Abstract Camurati-Engelmann disease or progressive diaphyseal dysplasia is a rare hereditary disease that results in a symmetrical hyperostosis of the long bones (cortical thickening) and/or the base of the skull. Camurati-Engelmann disease is also associated with myopathy and neurological manifestations. Clinically, Camurati-Engelmann disease typically presents with bone pain in the lower extremities, muscle weakness, and a wobbly, stilted gait. The disease is caused by mutations in the transforming growth factor-beta 1 gene. Up to date, about 300 cases have been described in the literature. In this case-based review, we present the clinical picture and genetic and radiological findings in a 20-yearold male patient we diagnosed with Camurati-Engelmann disease and our considerations in his treatment and compare the case to the literature. The diagnosis of Camurati-Engelmann disease was confirmed on patients' history, clinical and radiological findings, and genetic testing for transforming growth factor beta-1 mutation. The patient responded well to single therapy with zoledronic acid. Early diagnosis leads to improved clinical outcomes and increased quality of life in affected patients.
    Language English
    Publishing date 2023-02-01
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 2873727-1
    ISSN 2148-4279 ; 2147-9720
    ISSN (online) 2148-4279
    ISSN 2147-9720
    DOI 10.5152/eurjrheum.2023.21115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Lifestyle-Medikament Vitamin D. Was gibt es an Evidenz?

    Lange, Uwe / Schulz, Nils / Klemm, Philipp

    Zeitschrift fur Rheumatologie

    2023  Volume 82, Issue 10, Page(s) 877–881

    Abstract: An undersupply of 25-(OH) vitamin D3 (calcifediol) exists in many countries with moderate sunlight, long winters and only moderate fish consumption. Risk groups for vitamin D3 deficiency are older persons over 65 years, geriatric persons in nursing homes, ...

    Title translation Lifestyle medication vitamin D. What evidence is available?
    Abstract An undersupply of 25-(OH) vitamin D3 (calcifediol) exists in many countries with moderate sunlight, long winters and only moderate fish consumption. Risk groups for vitamin D3 deficiency are older persons over 65 years, geriatric persons in nursing homes, infants and children/adolescents. Therefore, there are also many situations in Germany which justify vitamin D substitution; however, vitamin D3 is currently praised as a "magic bullet" against everything. But what do the data look like? Where can it help and where can it not help?
    MeSH term(s) Child ; Infant ; Adolescent ; Animals ; Humans ; Aged ; Aged, 80 and over ; Vitamin D/therapeutic use ; Calcifediol/therapeutic use ; Cholecalciferol/therapeutic use ; Vitamin D Deficiency/drug therapy ; Life Style
    Chemical Substances Vitamin D (1406-16-2) ; Calcifediol (P6YZ13C99Q) ; Cholecalciferol (1C6V77QF41)
    Language German
    Publishing date 2023-07-28
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 124985-x
    ISSN 1435-1250 ; 0340-1855 ; 0301-6382
    ISSN (online) 1435-1250
    ISSN 0340-1855 ; 0301-6382
    DOI 10.1007/s00393-023-01392-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top